Loading clinical trials...
Loading clinical trials...
Additive Effects of Jacobson's Progressive Muscle Relaxation Technique With Aerobic Exercise on Cardiopulmonary Parameters and Quality of Life in Stage 1 Hypertensive Individuals
The study is a randomized controlled trial. The purpose of study is to compare the additive effects of Jacobson's progressive muscle relaxation technique with aerobic exercise versus aerobic exercise on cardiopulmonary parameters including systolic and diastolic blood pressure, heart rate, respiratory rate, rate pressure product and quality of life in stage 1 hypertensive individuals.
The study will consist of referred stage 1 hypertensive patients by medical specialist/cardiologist. Participants will be screened through PAR-Q and IPAQ Questionnaire. Cardiac monitor will be used for assessing the cardiopulmonary parameters. SF-36 Questionnaire will be used for assessing the quality of life. Informed written consent will be taken after which participants will be recruited into two groups. Control group will be provided aerobic exercise while interventional group will be provided Jacobson's progressive muscle relaxation technique with aerobic exercise. Outcome measures assessment will be done at pre-session, at 2 weeks and after 4 weeks post-intervention
Age
18 - 45 years
Sex
ALL
Healthy Volunteers
No
Foundation University College of Physical Therapy, Islamabad, 44000
Islamabad, Pakistan
Start Date
August 2, 2024
Primary Completion Date
June 5, 2025
Completion Date
June 5, 2025
Last Updated
September 15, 2025
40
ACTUAL participants
Interventional group: Jacobson's progressive muscle relaxation technique with aerobic exercise
OTHER
Aerobic Exercise
OTHER
Lead Sponsor
Foundation University Islamabad
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions